Candel Therapeutics, Inc.CADLNASDAQ
LOADING
|||
Switch Symbol:
Gross Profit Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year gross profit growth rate
Latest
19.42%
↑ 104% above average
Average (22q)
-451.96%
Historical baseline
Range
High:101.76%
Low:-8880.65%
Volatility
-1987.4%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 19.42% |
| Q2 2025 | 1.22% |
| Q1 2025 | 0.00% |
| Q4 2024 | 95.35% |
| Q3 2024 | -8.77% |
| Q2 2024 | -1831.08% |
| Q1 2024 | 19.55% |
| Q4 2023 | 94.54% |
| Q3 2023 | 1.70% |
| Q2 2023 | 0.00% |
| Q1 2023 | 100.00% |
| Q4 2022 | 7.42% |
| Q3 2022 | -7.11% |
| Q2 2022 | 7.42% |
| Q1 2022 | -62.77% |
| Q4 2021 | 38.12% |
| Q3 2021 | -60.50% |
| Q2 2021 | -19.80% |
| Q1 2021 | -8880.65% |
| Q4 2020 | 0.00% |
| Q3 2020 | 101.76% |
| Q2 2020 | -10.94% |
| Q1 2020 | 0.00% |